Yttrium (90Y) tacatuzumab tetraxetan: Difference between revisions
Content deleted Content added
mNo edit summary |
remove 'image = {{PAGENAME}}.png' from drugbox, see template talk:drugbox using AWB |
||
| Line 1: | Line 1: | ||
{{drugbox | |
{{drugbox | |
||
| IUPAC_name = |
| IUPAC_name = |
||
| image |
| image = |
||
| CAS_number = |
| CAS_number = |
||
| ATC_prefix = |
| ATC_prefix = |
||
Revision as of 14:02, 25 February 2007
Tacatuzumab tetraxetan is a humanized monoclonal antibody and which it's used to treat cancer. Tacatuzumab has a chelator, tetraxetan. It has a radioisotope, yttrium-99Y.
 | This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |